Follow
EQL Pharma AB
Spotlight (Sweden)
EQL Pharma is a pharmaceutical company. Currently, the focus is on development of niche and specialised pharmaceuticals, including everything from pharma for the treatment of diabetes, enlargement of blood vessels, as well as various infections and allergies. Primarily business is found in the Nordic market. EQL Pharma was founded in 2006 and is based in Lund.
Sector:
HEALTH CARE
>
Pharmaceuticals
Current instruments
Instruments & Events
The shares and options available for this company. Including past events like IPOs, direct listings and exercise periods.
Show archived
Type
Ticker
ISIN
Market
SHARE
EQL
SE0005497732
Spotlight
Sweden (SE)
Details of share in EQL Pharma AB with ticker EQL
Status
Active
Order book id
411U
Amount of instruments
29 063 610
Par value
0.0450
Market cap
578 400 000.00 SEK
Currency
SEK
Segment
SPOTLIGHT NEXT
First trading date
17 Dec 2013
Terms
Type
Price
Pre-money valuation
Time
Files
IPO
5.00 SEK
59.4M SEK
05 Nov - 19 Nov 2013
IPO in EQL Pharma AB
Type
Price
Pre-money valuation
Time
Files
New issue
3.50 SEK
47.2M SEK
26 Aug - 11 Sep 2014
Share issue in EQL Pharma AB
Type
Price
Pre-money valuation
Time
Files
Exercise
6.81 SEK
07 Oct - 28 Oct 2014
Option exercise terms for EQL TO 1
Type
Price
Pre-money valuation
Time
Files
Exercise
3.50-5.50 SEK
16 Mar - 30 Mar 2015
15 Sep - 30 Sep 2015
Option exercise terms for EQL TO 2
Type
Price
Pre-money valuation
Time
Files
Targeted issue
5.00 SEK
82.6M SEK
22 Sep 2015
-
Share issue in EQL Pharma AB
Type
Price
Pre-money valuation
Time
Files
New issue
6.00 SEK
149.4M SEK
30 Oct - 13 Nov 2018
Share issue in EQL Pharma AB
Type
Price
Pre-money valuation
Time
Files
Market move
2020
-
Listing of EQL Pharma AB on NASDAQ STOCKHOLM
Type
Ticker
ISIN
Market
SHARE
EQL
SE0005497732
Spotlight
Sweden (SE)
Details of share in EQL Pharma AB with ticker EQL
Status
Active
Order book id
411U
Amount of instruments
29 063 610
Par value
0.0450
Market cap
578 400 000.00 SEK
Currency
SEK
Segment
SPOTLIGHT NEXT
First trading date
17 Dec 2013
Terms
Type
Price
Pre-money valuation
Time
Files
IPO
5.00 SEK
59.4M SEK
05 Nov - 19 Nov 2013
IPO in EQL Pharma AB
Type
Price
Pre-money valuation
Time
Files
New issue
3.50 SEK
47.2M SEK
26 Aug - 11 Sep 2014
Share issue in EQL Pharma AB
Type
Price
Pre-money valuation
Time
Files
Targeted issue
5.00 SEK
82.6M SEK
22 Sep 2015
-
Share issue in EQL Pharma AB
Type
Price
Pre-money valuation
Time
Files
New issue
6.00 SEK
149.4M SEK
30 Oct - 13 Nov 2018
Share issue in EQL Pharma AB
Type
Price
Pre-money valuation
Time
Files
Market move
2020
-
Listing of EQL Pharma AB on NASDAQ STOCKHOLM
Type
Ticker
ISIN
Market
OPTION
EQL TO 1
SE0005497740
Spotlight
Sweden (SE)
Details of option in EQL Pharma AB with ticker EQL TO 1
Status
Archived
Order book id
Amount of instruments
640 000
Market cap
Currency
SEK
First trading date
Terms
As a result of the rights issue in EQL Pharma, the terms of the TO 1 warrant (ISIN code SE0005497740) have been restated. Following the recalculation, one (1) warrant entitles TO 1 to subscribe for 1.03 shares in EQL Pharma. The new exercise price after the conversion is SEK 6.81 per new share in EQL Pharma. The exercise period for TO 1 will be October 7, 2014 to October 28, 2014. The last day for trading in warrants TO 1 will be Thursday, October 23, 2014.
Type
Price
Pre-money valuation
Time
Files
Exercise
6.81 SEK
07 Oct - 28 Oct 2014
Option exercise terms for EQL TO 1
Type
Ticker
ISIN
Market
OPTION
EQL TO 2
SE0006219838
Spotlight
Sweden (SE)
Details of option in EQL Pharma AB with ticker EQL TO 2
Status
Archived
Order book id
Amount of instruments
Market cap
Currency
SEK
First trading date
Terms
The right to subscribe for the new shares and warrants TO 2 shall, with preferential rights, accrue to the shareholders in relation to the number of shares they previously own, meaning that the shareholders have the right to subscribe for one (1) Unit, containing two (12) for twelve (12) existing shares. new shares and one (1) warrant TO 2.
Terms for warrants TO 2 in summary. One (1) subscription option TO 2 gives the right to subscribe for one (1) new share in EQL Pharma. The subscription price shall be 70 percent of the volume-weighted trading price of SPOTLIGHT during the period of 10 trading days ending five banking days before the first subscription date, but not less than SEK 3.50 and a maximum of SEK 5.50. The subscription period is: 16 - 30 March 2015; or 15 - 30 September 2015.
Type
Price
Pre-money valuation
Time
Files
Exercise
3.50-5.50 SEK
16 Mar - 30 Mar 2015
15 Sep - 30 Sep 2015
Option exercise terms for EQL TO 2
People
Christer Fåhraeus
CEO
Ingemar Kihlström
Chairman of the board
Anders Månsson
Board member
Christer Fåhraeus
Board member
Lars Holmqvist
Board member
Maria Bech
Board member
Rajiv I. Modi
Board member
Company Details
Sector
HEALTH CARE
Website

Address
Stortorget 1 1tr
Zip code
222 23
City/district
Lund
Country
Sweden (SE)
Registration number
556713-3425
LEI code
549300Q8B2D2AE8GCW21
First trade date
17 Dec 2013
Registration date
19 Oct 2006
Short name
EQL Pharma

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More

Create Your FREE Account to stay Up To Date